Embracing a Collaboration Network Model for Discovery Research

Add bookmark

Life sciences companies are fundamentally changing the way they operate by routinely externalizing non-core competencies to external partners and service providers.

Today, Pharma companies spend almost one third of their global research budgets with external partners, and a 20% year-on-year growth is expected, resulting in 30-50% of all research activity to be undertaken by external partners. As part of the life science industry's transformation, there has been a fundamental change in the way companies operate.

Download this Technology Spotlight to hear where Alan Louie from IDC Health Insights, discusses the emerging industry trend of Externalized Collaboration and how this new model can be supported by a web-based collaboration network, which eliminates the need for dedicated physical infrastructure while providing a full featured, regulatory compliant collaborative workspace for researchers to share from anywhere in the world.

By IDC Health Insight

Have Your Say
Rate this feature and give us your feedback in the comments section below

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended